Part 1. Introduction

• 1.1 Market Definition
• 1.2 Key Benefit
• 1.3 Market Segment

Part 2. Methodology

• 2.1 Primary
• 2.2 Secondary

Part 3. Executive Summary

Part 4. Market Overview

• 4.1 Introduction
• 4.2 Market Size and Forecast
• 4.3 Market Dynamics
  • 4.3.1 Drivers
  • 4.3.2 Restraints
• 4.4 Impact of COVID-19 Pandemic

Part 5. Global Market for Cancer Biomarkers by Profiling

• 5.1 Cytogenetics-Based Tests
  • 5.1.1 Market Size and Forecast
• 5.2 Imaging Technologies
  • 5.2.1 Market Size and Forecast
• 5.3 Immunoassays
  • 5.3.1 Market Size and Forecast
• 5.4 Omic Technologies
  • 5.4.1 Market Size and Forecast

Part 6. Global Market for Cancer Biomarkers by Cancer Type

• 6.1 Breast Cancer
  • 6.1.1 Market Size and Forecast
• 6.2 Colorectal Cancer
  • 6.2.1 Market Size and Forecast
• 6.3 Lung Cancer
  • 6.3.1 Market Size and Forecast
• 6.4 Prostate Cancer
  • 6.4.1 Market Size and Forecast
• 6.5 Stomach Cancer
  • 6.5.1 Market Size and Forecast
• 6.6 Others
  • 6.6.1 Market Size and Forecast

Part 7. Global Market for Cancer Biomarkers by Application

• 7.1 Diagnostics
  • 7.1.1 Market Size and Forecast
• 7.2 Drug Discovery & Development
  • 7.2.1 Market Size and Forecast
• 7.3 Prognostics
  • 7.3.1 Market Size and Forecast
• 7.4 Risk Assessment
  • 7.4.1 Market Size and Forecast
• 7.5 Others
  • 7.5.1 Market Size and Forecast

Part 8. Global Market for Cancer Biomarkers by Region

• 8.1 Asia-Pacific
  • 8.1.1 Market Size and Forecast
• 8.2 Europe
  • 8.2.1 Market Size and Forecast
• 8.3 North America
  • 8.3.1 Market Size and Forecast
• 8.4 Middle East And Africa (Mea)
  • 8.4.1 Market Size and Forecast
• 8.5 South America
  • 8.5.1 Market Size and Forecast

Part 9. Key Competitor Profiles

• 9.1 Abbott Laboratories
• 9.2 Bio-rad laboratories, Inc.
• 9.3 Bristol-Myers Squibb (BMS) Company
• 9.4 EXACT Sciences Corporation
• 9.5 Merck KGaA
• 9.6 PerkinElmer, inc.
• 9.7 Qiagen N.V.
• 9.8 Roche Holding AG
• 9.9 Siemens AG
• 9.10 Thermo Fisher Scientific, Inc.

*LIST IS NOT EXHAUSTIVE

Part 10. Patent Analysis

• 10.1 Patent Statistics
• 10.2 Regional Analysis
• 10.3 Trends Analysis

DISCLAIMER

ABOUT GEN CONSULTING COMPANY

The global cancer biomarkers market is projected to grow at a compound annual growth rate (CAGR) of 12.27% during the forecast period 2021-2027, according to the new report published by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global cancer biomarkers market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, company share of market leaders, growth rate and market segments.

The cancer biomarkers market is segmented on the basis of profiling, cancer type, application, and region. The cancer biomarkers market is segmented as below:

By Profiling:
- cytogenetics-based tests
- imaging technologies
- immunoassays
- omic technologies

By Cancer Type:
- breast cancer
- colorectal cancer
- lung cancer
- prostate cancer
- stomach cancer
- others

By Application:
- diagnostics
- drug discovery & development
- prognostics
- risk assessment
- others

By Region:
- region
- Asia-Pacific
- Europe
- North America
- Middle East and Africa (MEA)
- South America

The market research report covers the analysis of key stake holders of the cancer biomarkers market. Some of the leading players profiled in the report include Abbott Laboratories, Bio-rad laboratories, Inc., Bristol-Myers Squibb (BMS) Company, EXACT Sciences Corporation, Merck KGaA, PerkinElmer, inc., Qiagen N.V., Roche Holding AG, Siemens AG, Thermo Fisher Scientific, Inc., among others.
*list is not exhaustive, request free sample to get a complete list of companies

Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global cancer biomarkers market.
- To classify and forecast the global cancer biomarkers market based on profiling, cancer type, application, and region.
- To identify drivers and challenges for the global cancer biomarkers market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global cancer biomarkers market.
- To conduct pricing analysis for the global cancer biomarkers market.
- To identify and analyze the profile of leading players operating in the global cancer biomarkers market.

Why Choose This Report
- Gain a reliable outlook of the global cancer biomarkers market forecasts from 2021 to 2027 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.